Bibliography

Export 44 results:
Filters: Keyword is *Blood Donors  [Clear All Filters]
2015
Seed CR, Maloney R, Kiely P, Bell B, Keller AJ, Pink J, et al. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme. Vox sanguinis// // Vox Sang. 2015;108(2):113-22.
Jungbauer C, Hourfar MK, Stiasny K, Aberle SW, Cadar D, Schmidt-Chanasit J, et al. West Nile virus lineage 2 infection in a blood donor from Vienna, Austria, August 2014. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology// J Clin Virol. 2015;64:16-9.
2014
Biceroglu SU, Turhan A, Doskaya AD, Yamazhan T, Donmez A, Altuglu I, et al. Probable hepatitis C virus transmission from a seronegative blood donor via cellular blood products. Blood transfusion = Trasfusione del sangue// Blood Transfus.. 2014;12 Suppl 1:s69-70.
Jackson BR, Kucerova Z, Roy SL, Aguirre G, Weiss J, Sriram R, et al. Serologic survey for exposure following fatal Balamuthia mandrillaris infection. Parasitology research// Parasitol Res. 2014;113(4):1305-11.
Lanteri MC, Lee T-, Wen L, Kaidarova Z, Bravo MD, Kiely NE, et al. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion// Transfusion. 2014;54(12):3232-41.
2013
Allain J-, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshoj L, Garcia JM, et al. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion// Transfusion. 2013;53(7):1405-15.
Bianco C, Dodd RY. Infectivity of occult hepatitis B from two different points of view. Transfusion// Transfusion. 2013;53(7):1379-81.
2012
Johnson ST, Cable RG, Leiby DA. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion// Transfusion. 2012;52(7):1509-16.
Jereb M, Pecaver B, Tomazic J, Muzlovic I, Avsic-Zupanc T, Premru-Srsen T, et al. Severe human granulocytic anaplasmosis transmitted by blood transfusion. Emerging infectious diseases// Emerg Infect Dis. 2012;18(8):1354-7.
Bloch EM, Herwaldt BL, Leiby DA, Shaieb A, Herron RM, Chervenak M, et al. The third described case of transfusion-transmitted Babesia duncani. Transfusion// Transfusion. 2012;52(7):1517-22.
2011
Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion//Transfusion. 2011;51(8):1716-22.
Wieling W, France CR, van Dijk N, Kamel H, Thijs RD, Tomasulo P. Physiologic strategies to prevent fainting responses during or after whole blood donation. Transfusion. 2011;51(12):2727-38.
2010
Guntz P, Walter C, Schosseler P, Morel P, Coste J, Cazenave JP. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples. Transfusion. 2010;50(5):989-95.
2009
Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-11.
Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka A, Scheinberg P, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion//Transfusion. 2009;49(9):1845-9.
West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(45):1263-7.
2008
de la Rubia J, de Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008;93(5):735-40.
Pamphilon D, Nacheva E, Navarrete C, Madrigal A, Goldman J. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors. Transfusion. 2008;48(7):1495-501.
2006
Karadogan C, Karadogan I, Bilgin AU, Undar L. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors. Ther Apher Dial. 2006;10(2):180-6.
2005
Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner JE, et al. First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood. 2005;106(13):4377-80.
Au WY, Lie AK, Cheng VC. Hematopoietic progenitor cell transplantation from a donor with indeterminate human immunodeficiency virus antibody status. Transfusion. 2005;45(5):819-20.
Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, et al. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang. 2005;88(4):289-303.
Pulsipher MA, Levine JE, Hayashi RJ, Chan KW, Anderson P, Duerst R, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005;35(4):361-7.
2004
Arat M, Arslan O, Ayyildiz E, Topcuoglu P, Dalva K, Ilhan O. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience. Transfusion & Apheresis Science. 2004;30(3):189-91.
Covin RB, Rich NL, Aysola A. Upper-extremity deep venous thrombosis complicating whole-blood donation. Transfusion. 2004;44(4):586-90.

Pages